153 related articles for article (PubMed ID: 18822104)
1. Intrathecal chemoprophylaxis after HSCT in children.
Rubin J; Frost BM; Arvidson J; Wide K; Gustafsson-Jernberg A; Gustafsson B
Pediatr Transplant; 2008 Dec; 12(8):889-95. PubMed ID: 18822104
[TBL] [Abstract][Full Text] [Related]
2. Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse.
Rubin J; Vettenranta K; Vettenranta J; Bierings M; Abrahamsson J; Békássy AN; Håkansson Y; Frost BM; Arvidson J; Spendilow C; Winiarski J; Gustafsson B
Bone Marrow Transplant; 2011 Mar; 46(3):372-8. PubMed ID: 20498650
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
4. Utility of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia.
Alexander BM; Wechsler D; Braun TM; Levine J; Herman J; Yanik G; Hutchinson R; Pierce LJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1191-6. PubMed ID: 15978741
[TBL] [Abstract][Full Text] [Related]
5. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation.
Parkman R; Cohen G; Carter SL; Weinberg KI; Masinsin B; Guinan E; Kurtzberg J; Wagner JE; Kernan NA
Biol Blood Marrow Transplant; 2006 Sep; 12(9):919-27. PubMed ID: 16920557
[TBL] [Abstract][Full Text] [Related]
6. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
[TBL] [Abstract][Full Text] [Related]
7. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
9. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience.
Rubnitz JE; Lensing S; Zhou Y; Sandlund JT; Razzouk BI; Ribeiro RC; Pui CH
Cancer; 2004 Oct; 101(7):1677-84. PubMed ID: 15378506
[TBL] [Abstract][Full Text] [Related]
10. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
Choi SW; Boxer LA; Pulsipher MA; Roulston D; Hutchinson RJ; Yanik GA; Cooke KR; Ferrara JL; Levine JE
Bone Marrow Transplant; 2005 Mar; 35(5):473-7. PubMed ID: 15640815
[TBL] [Abstract][Full Text] [Related]
11. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V
Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
13. The influence of traumatic lumbar puncture and timing of intrathecal therapy on outcome of pediatric acute lymphoblastic leukemia.
Rech A; de Carvalho GP; Meneses CF; Hankins J; Howard S; Brunetto AL
Pediatr Hematol Oncol; 2005 Sep; 22(6):483-8. PubMed ID: 16169814
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL.
Fukano R; Nishimura M; Ito N; Nakashima K; Kodama Y; Okamura J; Inagaki J
Pediatr Transplant; 2014 Aug; 18(5):518-23. PubMed ID: 24815062
[TBL] [Abstract][Full Text] [Related]
16. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
17. Children with hyperdiploid but not triple trisomy (+4,+10,+17) acute lymphoblastic leukemia have an increased incidence of extramedullary relapse on current therapies: a single institution experience.
Sharathkumar A; DeCamillo D; Bhambhani K; Cushing B; Thomas R; Mohamed AN; Ravindranath Y; Taub JW
Am J Hematol; 2008 Jan; 83(1):34-40. PubMed ID: 17696201
[TBL] [Abstract][Full Text] [Related]
18. Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference.
Locatelli F; Pende D; Maccario R; Mingari MC; Moretta A; Moretta L
Clin Immunol; 2009 Nov; 133(2):171-8. PubMed ID: 19481979
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
Claviez A; Sureda A; Schmitz N
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S16-24. PubMed ID: 18978738
[TBL] [Abstract][Full Text] [Related]
20. Place of HSCT in treatment of childhood AML.
Klingebiel T; Reinhardt D; Bader P;
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S7-9. PubMed ID: 18978749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
